As Congressional lawmakers push to negotiate prices for Medicare Part D, a new analysis finds the federal government could have saved $14.4 billion on the top 50 pills that were covered two years ago if the program obtained the same prices as the Department of Veterans Affairs, which already haggles for discounts.

For instance, the Part D plan spent $3 billion on the Harvoni hepatitis C treatment sold by Gilead Sciences (GILD) in 2016 – more on this particular pill that year than any other oral medicine – but could have spent $1.7 billion if using VA pricing. Similarly, the program spent $1.8 billion on the Revlimid cancer treatment sold by Celgene  (CELG), but could have spent $1.2 billion with VA prices.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
  • Medicare have the nerve to put on my prescription form that when I pay $47 for my insulin they saved me over $900, I can get in Mexico for $120 which I have to do due to donut hole being achieved very quickly at those ridiculous prices. Clinton negotiated with the pharmaceutical companies that would not let Medicare negotiate with them. This needs to change or we should buy exactly same medications from Mexico and bypass the greedy big business in the U.S

  • If Medicare part D was watching the PBM’s they would have saved 30 Billion
    in 2016. There has to be total transparency dealing with the PBM’s ! That is the ONLY way the government will save money. After all they have no laws governing them. So they really do whatever they want to do. And there are no laws to stop them ! PBM’s want everything to stay the same. If they do stay the same, I can assure you, there will not be one Independent pharmacy left in this country.

  • And why doesn’t Part D negotiate prices? If memory serves NOT doing that was because Big Pharma came to the table for the ACA and negotiated that. (Just sayin’ …. )

Comments are closed.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy